文献速递乳腺乳腺X线

DBT与DM人群筛查间期浸润性乳腺癌的Meta分析

Interval Invasive Cancers in Population Screening: A Meta-analysis of Digital Breast Tomosynthesis vs. Digital Mammography.
PubMed 文献 · Acad Radiol · 2026-09-10

总体上DBT未显示有统计学意义的降低,按筛查间隔分层的亚组描述性分析亦未提示DBT与DM间存在有意义的差异。

要点

  • DBT较DM未显著降低间期浸润性乳腺癌发生率,解读筛查阴性结果时不宜因DBT而放宽对间期癌的警惕。
  • 间期癌可能更多反映肿瘤生物学侵袭性或乳腺X线隐匿性,而非单纯病灶显示度的不足。

核心结论

  • 在超过140万次筛查中,DBT与DM相比未显示有意义的间期浸润性乳腺癌发生率降低。

研究设计与样本

  • 纳入标准为报告阴性筛查后至下一轮预定筛查前诊断的间期浸润性癌,并提供按模态分层的分母及间期癌例数。
  • 合并效应量采用Mantel-Haenszel共同效应模型及逆方差随机效应模型,研究间方差采用Paule-Mandel估计。
  • 研究按设计类型(随机试验与观察性队列)及预定筛查间隔(年度与非年度)进行预设亚组分析,3项为年度筛查、10项为非年度筛查。

关键影像表现/征象

  • 共记录4370例间期浸润性乳腺癌,DBT与DM组间期癌发生率的绝对风险差未显示统计学显著差异。
  • 随机试验与观察性队列的结果一致,未提示DBT在降低间期浸润性癌方面具有优势。
  • 按年度与非年度筛查间隔的亚组描述性分析未提示DBT与DM之间在间期癌发生率上存在有意义的差异。

诊断标准与关键数值

  • 主要效应指标为绝对风险差,定义为DBT减去DM的间期浸润性乳腺癌发生率之差。

临床应用与阅片要点

  • 在人群乳腺X线筛查阅片中,不必因使用DBT而改变对阴性筛查后新发症状或体征的随访阈值。
  • 报告间期癌随访数据时,应理解DBT改善病灶显示度可能对生物学侵袭性强、进展快或乳腺X线隐匿性癌影响有限。

局限性

  • 该Meta分析为基于纳入研究水平的汇总分析,未提供个体层面乳腺密度、肿瘤生物学特征等信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To evaluate whether digital breast tomosynthesis (DBT) reduces the incidence of invasive interval breast cancers compared with digital mammography (DM) in population-based breast screening studies, and whether this effect differs by screening interval.

MATERIALS AND METHODS: We performed a systematic review and meta-analysis of comparative screening studies evaluating invasive interval breast cancers after negative screening examinations with DBT versus DM. Eligible studies reported modality-specific denominators and invasive interval cancers diagnosed after a negative screening examination and before the next scheduled screening round. The primary effect measure was the absolute risk difference, defined as DBT minus DM. Pooled estimates were calculated using Mantel-Haenszel common-effect and inverse-variance random-effects models with Paule-Mandel estimation of between-study variance. Prespecified subgroup analyses were performed by study design and intended screening interval, classified as annual or nonannual.

RESULTS: Thirteen studies were included, comprising 1407,624 screening examinations, including 548,368 DBT examinations and 859,256 DM examinations, with 4370 invasive interval breast cancers. Three studies were classified as annual screening studies and 10 as nonannual screening studies. Overall, DBT was not associated with a statistically significant reduction in invasive interval breast cancer incidence compared with DM. Results were consistent across randomized trials and observational cohorts. Descriptive subgroup analyses by screening interval did not suggest a meaningful difference in interval cancer incidence between DBT and DM.

CONCLUSION: Across more than 1.4 million screening examinations, DBT was not associated with a meaningful reduction in invasive interval breast cancer incidence compared with DM. These findings suggest that improved mammographic lesion conspicuity with DBT may not substantially affect cancers that are biologically aggressive, rapidly developing, or mammographically occult.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Ferre, Benefield, Kuzmiak, et al. Interval Invasive Cancers in Population Screening: A Meta-analysis of Digital Breast Tomosynthesis vs. Digital Mammography. Acad Radiol. 2026. PMID: 42722554. doi:10.1016/j.acra.2026.08.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。